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patients from the general population (42.2%). The adjusted 
odds ratios (OR) of patients with chronic somatic diseases 
were significantly elevated for mental disorders in compari-
son with healthy probands (OR: 2.2). Mood, anxiety and so-
matoform disorders were most frequent. The prevalence 
rates did not differ significantly between the somatic index 
diseases. The number of somatic diseases per patient had a 
higher association with mental disorders.  Conclusions: 
There is a strong relationship between chronic somatic dis-
eases and mental disorders. A future task is to improve the 
care of mental disorders in patients with chronic physical ill-
ness, specifically with multimorbid conditions. 
 Copyright © 2007 S. Karger AG, Basel 
 A close relationship has consistently been reported be-
tween somatic diseases, mental disorders and the nega-
tive impact of comorbid mental disorders on mortality, 
quality of life and health costs  [1–7] . Although many pa-
tients with chronic somatic diseases suffer from mental 
disorders  [8–16] , the extent to which patients with chron-
ic somatic diseases are, in general, at increased risk of 
experiencing mental disorders remains unexplored.
 Only a small number of studies have shown that prev-
alence rates of mental disorders adjusted for demograph-
ic variables (e.g. age and sex) are higher in patients with 
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 Abstract 
 Background: Although it is well established that chronic so-
matic diseases are significantly associated with a wide range 
of psychopathology, it remains unclear to what extent sub-
jects with chronic somatic diseases are at increased risk of 
experiencing mental disorders. The present epidemiologi-
cal study investigates age- and sex-adjusted 12-month prev-
alence rates of mental disorders in patients with cancer, and 
musculoskeletal, cardiovascular and respiratory tract diseas-
es, based on comprehensive physicians’ diagnoses and com-
pared with physically healthy probands.  Methods: Preva-
lence rates were calculated from two large epidemiological 
surveys. These studies investigated inpatients and patients 
from the general population with cancer (n = 174) and mus-
culoskeletal (n = 1,416), cardiovascular (n = 915) and respira-
tory tract diseases (n = 453) as well as healthy controls (n = 
1,083). The prevalence rates were based on the Munich Com-
posite International Diagnostic Interview, a standardized in-
terview for the assessment of mental disorders.  Results: 
Prevalence rates were very similar for inpatients (43.7%) and 
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chronic somatic diseases than in a physically healthy 
comparison group. Most of these studies focused on spe-
cific somatic diseases, e.g. asthma, cancer, chronic spinal 
pain and atherosclerosis  [9, 10–14] , while others focused 
on certain mental disorders such as somatoform or affec-
tive disorders  [8, 13] . The only study to comprise a broad-
er range of somatic diseases and mental disorders was the 
NIMH Epidemiologic Catchment Area Study  [16] , but 
this study had several limitations: (1) it was based on 
DSM-III criteria and focused only on the categories ‘af-
fective disorders’, ‘anxiety disorders’ and ‘substance-re-
lated disorders’; (2) diagnoses of chronic somatic diseases 
originated only from patients’ self-evaluations and were 
not based on physicians’ diagnoses; (3) patients were se-
lected from the general population, and therefore did not 
include inpatients.
 In the present study, for the first time, the frequency 
of mental disorders in patients with somatic diseases di-
agnosed by physicians in comparison with physically 
healthy probands will be investigated. The following 4 
questions will be addressed:
 1 Do prevalence rates of mental disorders differ between 
patients from different settings (inpatient setting vs. 
general population)? 
 2 What are the age- and sex-adjusted 12-month preva-
lence rates of mental disorders according to DSM-IV 
in patients with frequent chronic somatic diseases 
(musculoskeletal diseases, cardiovascular diseases, re-
spiratory tract diseases and cancer)? 
 3 Do prevalence rates of mental disorders differ between 
musculoskeletal diseases, cardiovascular diseases, re-
spiratory tract diseases and cancer? 
 4 Is somatic comorbidity associated with the prevalence 
of mental disorders? 
 Methods 
 Study Design and Samples 
 Patients with chronic somatic diseases and healthy probands 
were selected from the German National Health Interview and 
Examination Survey Mental Health Supplement (GHS-MHS) and 
the Epidemiology of Mental Disorders in Medical Rehabilitation 
Study (EMDMR). Both studies were based on epidemiological 
sampling procedures. The 2-stage cross-sectional design included 
(1) the screening of representative population samples and (2) 
stratified random sampling of probands for diagnostic interview.
 (a) The GHS-MHS was the first nationwide epidemiological 
study of mental health carried out in the adult general population 
in Germany  [17, 18] . The data collection for the GHS-MHS was 
based on a 2-stage procedure: first, all participants of the GHS 
Core Survey (n = 7,124) were screened for mental disorders using 
the screening questionnaire  [19]  of the Munich Composite Inter-
national Diagnostic Interview (M-CIDI) and diagnosed as having 
a somatic illness. The somatic examination took place in special 
centers at the study sites and began with a self-report questionnaire 
to evaluate the subjects’ current and past somatic symptoms and 
complaints, health care utilization, impairments and disabilities. 
Completion of the questionnaires was followed by a structured 
interview conducted by a study physician in order to reexamine 
and refine the data from the self-report packet. This interview was 
computer assisted for standardization and integrity purposes 
(computer-aided personal interview). Diagnoses were then sup-
plemented and, depending on the medical condition, revised on 
the basis of laboratory test data, which were available 2 weeks later. 
The mean duration of the overall assessment was 2 h  [10] .
 Second, all participants who screened positively according to 
the screening interview of the M-CIDI and 50% of those who 
screened negatively were examined by means of a standardized 
clinical interview for mental disorders (M-CIDI; n = 4,181  [17] ). 
All probands of the GHS-MHS with diagnosed cancer or muscu-
loskeletal, cardiovascular or respiratory tract diseases present 
within the previous 12 months were included in this study (n = 
1,662).
 The physically healthy comparison group included all pro-
bands of the GHS-MHS who were not diagnosed as having 1 of 
the 4 somatic index diseases or any other chronic somatic disease 
within the previous 12 months (n = 1,083).
 (b) The EMDMR Study examined the frequency of mental dis-
orders among inpatients with cancer or musculoskeletal, cardio-
vascular or respiratory tract diseases. The sample originated from 
16 German inpatient rehabilitation centers. Patient recruitment 
was based on a 2-stage procedure analogous to the sampling pro-
cedure of the World Health Organization study on mental illness 
in general health care  [15] : all newly admitted patients were 
screened by means of the General Health Questionnaire (GHQ; 
 n = 2,902  [20] ). Ten percent of low GHQ-12 scorers (0–4), 30% of 
medium GHQ-12 scorers (5–7) and 50%  of high GHQ-12 scorers 
(8–12) were then selected randomly for the standardized clinical 
M-CIDI (n = 648  [21] ). All inpatients passed through a compre-
hensive diagnostic procedure based on the patients’ admission 
reports, laboratory test data and a complete physical examination. 
Physicians were instructed to document all diagnoses according 
to ICD-10 using a standardized medical chart. This procedure 
was very similar to the physicians’ interview (computer-aided 
personal interview) used in the GHS.
 Assessment and Interviewers 
 In both epidemiological studies, mental disorders were as-
sessed using the M-CIDI in the DIA-X version  [22] . It enables a 
reliable and efficient assessment of symptoms, syndromes and di-
agnoses of mental disorders, along with information about age of 
onset, duration of symptoms and clinical and psychosocial sever-
ity. The main advantages of this procedure are its high objectivity 
and test-retest reliability (  : 0.56–0.78  [22] ). The M-CIDI was 
used to determine the presence of substance abuse/dependence, 
mood, anxiety and somatoform disorders according to DSM-IV 
criteria. All interviewers were clinically experienced psycholo-
gists, physicians or other health professionals. The interviewers 
received standardized interview training for conducting the 
M-CIDI interviews, consequently warranting a high reliability. 
Interviewers were monitored closely and supervised by trained 
M-CIDI clinical supervisors  [17, 21] .
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 Data Analysis 
 The data analysis was completed using Stata Statistical Soft-
ware     [23] . Statistical weighting procedures were used to com-
pensate for the oversampling of probands  [17, 21] . For example, 
with regard to the GHS-MHS, screen negatives received twice the 
weight of screen positives. The average weight was set to 1  [17] . 
Analogous sampling weights were calculated for patient sub-
groups with high, medium or low GHQ scores within the EMD-
MR study  [21] . Within the GHS-MHS, subjects were further 
weighted to adjust the sample to match the age, sex and regional 
distribution of the national administrative statistics in Germany 
 [17] . These weighting procedures allow for representative analy-
ses for both the inpatient sample and the general population sam-
ple. The weighted distribution of 12-month mental disorders (yes/
no) in somatically ill sample patients was compared with the 
healthy comparison group by logistic regression, controlling for 
age and sex. Regression coefficients were transformed to odds ra-
tios (OR). Based on the weighted 12-month prevalence rates of the 
physically healthy comparison group, prevalence rates of somati-
cally ill patients were calculated using the estimated OR. Thus, 
one would expect prevalence rates of mental disorders to be illus-
trated in the physically ill samples if their age and sex distribution 
corresponded with the distribution in the healthy sample. In or-
der to carry out a correct weighting and stratification of the ran-
dom samples, the Stata SVY (survey) commands were used. These 
commands enable an adequate handling of weighted and strati-
fied data. Between-patient-group comparisons were conducted 
via the logistic regression using a postestimator (lincom), which 
enables a comparison of coefficients on significant differences.
 Results 
 The total sample consisted of 3,393 probands, who 
were interviewed using the standardized clinical inter-
view. A total of 2,310 probands entered the patient group, 
manifesting at least 1 of the index diseases within the pre-
vious 12 months. During the same period, 1,083 pro-
bands were physically healthy. The mean age of the 
healthy probands was 36.3 years, and 40.6% were female. 
The mean age of the chronically ill probands was 49.8 
years, and 49.3% were female.
 The following 12-month prevalence rates of mental 
disorders are adjusted for age and sex. We excluded fur-
ther sample characteristics that may confound the preva-
lence rates of mental disorders. More detailed character-
istics comprising marital status, education, income and 
employment status of all 8 samples (patients in general, 
healthy controls, 4 disease groups, 2 settings) are avail-
able on request.
 Question 1 
 Inpatients (43.7%; OR: 2.3) and patients from the gen-
eral population (42.2%; OR: 2.2) showed a similarly in-
creased risk of having any mental disorder compared 
with healthy probands ( table 1 ). The increased risk was 
mainly due to significantly higher prevalence rates of 
mood disorders, anxiety disorders and somatoform dis-
orders in both patient samples. There were no significant 
differences between inpatients and patients from the gen-
eral population regarding prevalence rates of mood dis-
orders (OR: 1.2; confidence interval, CI: 0.9–1.5), anxiety 
disorders (OR: 1.1; CI: 0.9–1.4), any mental disorders 
(OR: 1.1; CI: 0.9–1.3) or the number of comorbid mental 
disorders (OR: 0.8; CI: 0.6–1.0). Somatoform disorders 
(OR: 0.6; CI: 0.4–0.8) and substance-related disorders 
(OR: 0.5; CI: 0.3–0.9) were significantly more frequent in 
Table 1. Sex- and age-adjusted 12-month prevalence rates of DSM-IV mental disorders in patients from two 
different samples (inpatients and patients from the general population) in comparison with healthy probands
Inpatients (n = 648) General population (n = 1,662) Healthy
(n = 1,083)
%% OR 95% CI % OR 95% CI
Total1 43.7 2.3* 1.8–3.0 42.2 2.2* 1.8–2.7 25.0
Mood disorders 23.2 2.9* 2.1–4.1 20.5 2.5* 1.9–3.3 9.4
Anxiety disorders 24.3 2.5* 1.8–3.4 22.5 2.2* 1.7–2.9 11.6
Somatoform disorders 10.7 2.0* 1.3–3.0 16.6 3.3* 2.3–4.6 5.7
Substance use disorders2 3.9 0.7 0.4–1.4 7.9 1.5 1.0–2.4 5.3
More than one disorder 18.0 2.9* 2.0–4.2 21.8 3.7* 2.7–5.0 7.1
* p < 0.01 (two-tailed). CI = Confidence interval. OR are based on the adjusted prevalence rates of the healthy 
comparison group.
1 At least one of the mentioned disorders.
2 Excluding nicotine dependence.
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patients from the general population. The similar rates of 
any mental disorder justify a comprehensive analysis of 
patients versus healthy probands from both samples.
 Question 2 
 The age- and sex-adjusted prevalence rate of mental 
disorders was significantly higher in patients with chron-
ic somatic diseases (42.5%) compared with physically 
healthy probands (25.0%; OR: 2.2;  table 2 ). Mood (21.1%) 
and anxiety disorders (22.9%) were most common in so-
matically ill patients as well as in healthy probands (9.4%; 
11.6%). The prevalence rates of mood (OR: 2.6) and anx-
iety disorders (OR: 2.3) differed significantly in patients 
versus healthy probands. The difference between physi-
cally ill (15.3%) and healthy probands (5.7%) was found 
to be most distinct for somatoform disorders (OR: 3.0). 
The prevalence rate of substance use disorders in patients 
with chronic somatic diseases (7.0%) did not differ sig-
nificantly from that of healthy controls (5.3%; OR: 1.3). 
Furthermore, patients (20.9%) displayed more than one 
mental disorder significantly more often than healthy 
probands (7.1%; OR: 3.5).
 Question 3 
 Patients with musculoskeletal (45.3%), cardiovascu-
lar (40.7%) and respiratory tract diseases (42.1%) showed 
comparably increased prevalence rates of mental disor-
ders ( table 2 ). Mood and anxiety disorders were most 
prevalent in patients who had respiratory tract diseases, 
whereas somatoform disorders co-occurred mainly in 
patients with musculoskeletal diseases. Patients with re-
spiratory tract diseases most often had more than one 
mental disorder. The prevalence rates of anxiety disor-
ders, somatoform disorders and substance use disorders 
were lowest for cancer patients. Moreover, cancer pa-
tients reported a lower rate of mental comorbidity. How-
ever, the ORs for any mental disorder were still high in 
all 4 disease groups when compared with healthy pro-
bands.
 Question 4 
 The amount of somatic comorbidity is associated with 
higher risks for mental disorders.  Table 3 shows increased 
prevalence rates for any mental disorder according to the 
number of somatic diseases. In comparison with healthy 
probands, patients with 3 or more somatic diseases, a 
subgroup accounting for more than half of all physically 
ill patients, showed the highest increase in prevalence 
rates of any mental disorders (OR: 2.8). However, preva-
lence rates of mental disorders still remain significantly 
increased for patients with only 1 somatic disease, with 
the exception of substance use disorders.
 Discussion 
 The present study is the first to compare age- and sex-
adjusted 12-month prevalence rates of mental disorders 
in patients with somatic diseases based on physicians’ di-
agnoses compared with healthy probands. The rationale 
for including a combination of inpatients and patients 
from the general population was to minimize selection 
Table 2. Sex- and age-adjusted 12-month prevalence rates of DSM-IV mental disorders in patients with a chronic illness in comparison 
with healthy probands
Patients (n = 2,310) Healthy
(n = 1,083)
%
Cancer (n = 174) MSD (n = 1,416) CVD (n =  915) RTD  (n = 453)
% OR 95% CI % OR 95% CI % OR 95% CI % OR 95% CI % OR 95% CI
Total1 42.5 2.2** 1.8–2.7 25.0 36.8 1.7* 1.1–2.7 45.3 2.5** 2.0–3.1 40.7 2.1** 1.5–2.7 42.1 2.2** 1.7–2.9
Mood disorders 21.1 2.6** 1.9–3.4 9.4 19.6 2.4** 1.3–4.2 20.4 2.5** 1.8–3.4 18.4 2.2** 1.5–3.3 22.7 2.8** 2.0–4.1
Anxiety disorders 22.9 2.3** 1.7–2.9 11.6 18.5 1.7* 1.0–3.0 23.4 2.3** 1.8–3.1 22.4 2.2** 1.5–3.1 24.5 2.5** 1.8–3.5
Somatoform
disorders 15.3 3.0** 2.1–4.2 5.7 9.1 1.7 0.7–3.8 18.0 3.6** 2.5–5.2 13.3 2.5** 1.6–4.1 14.0 2.7** 1.7–4.2
Substance use
disorders2 7.0 1.3 0.9–2.1 5.3 4.8 0.9 0.2–3.3 6.7 1.3 0.8–2.1 8.4 1.6 0.8–3.1 7.3 1.4 0.8–2.5
More than one
disorder 20.9 3.5** 2.6–4.8 7.1 16.6 2.6** 1.3–5.2 20.8 3.5** 2.5–4.8 20.4 3.4** 2.2–5.2 23.7 4.1** 2.8–6.0
* p < 0.05, ** p < 0.01 (two-tailed). MSD = Musculoskeletal diseases; CVD = cardiovascular diseases; RTD = respiratory tract diseases. OR are based 
on the adjusted prevalence rates of the healthy comparison group.
1 At least one of the mentioned disorders.
2 Excluding nicotine dependence.
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bias, the so-called Berkson’s bias  [24] , which states that 
samples from the general population are restricted to the 
noninstitutionalized population.
 While 1 in 4 persons without somatic disease reported 
a mental disorder within the previous year, this percent-
age was almost twice as high among chronically ill pa-
tients. In addition, patients show an OR of 3.5 for having 
more than one mental disorder. The differences in overall 
prevalence rates between physically ill patients and 
healthy probands are due mainly to  higher frequencies of 
mood, anxiety, and somatoform disorders (OR: 2.3–3.0). 
In line with previous studies  [10, 11, 14, 16] , mood and 
anxiety disorders are most frequent in physically ill pa-
tients. However, while patients often rate the severity of 
their mood disorder as serious, there is a considerable 
amount of mild anxiety disorders, and in particular mild 
specific phobias, which can lead to an overemphasis of 
the need for treatment of anxiety disorders  [25] .
 Almost as frequent as affective and anxiety disorders 
are  somatoform disorders . A small number of epidemio-
logical studies have reported prevalence rates of somato-
form disorders  [8, 15, 18, 26, 27] . Somatization alone ac-
counts for approximately 16% of the yearly health care 
expenditure of the USA  [28] . However, problems with re-
liability and validity as well as difficulties in operational-
ization complicate the measurement of this diagnostic 
category, particularly in patients with somatic diseases 
 [8, 29, 30] . Patients may be more likely to attribute their 
symptoms to a somatic factor than healthy probands. 
Moreover, physically ill inpatients may have a more so-
matic attribution style than patients from the general 
population due to their intensive somatic treatment  [8] . 
However, our results underscore the fact that these disor-
ders also occur when they are associated with organic 
medical illness (see also the current debate on somato-
form disorders and DSM-V).
 Prevalence rates of  substance disorders are low com-
pared with previous studies  [16] . Beyond different clas-
sification algorithms (DSM-III vs. DSM-IV), a possible 
explanation for the lower prevalence rates may be that 
inpatients in particular tend to dissimulate their sub-
stance-related symptoms. This dissimulation may be due 
to possible negative consequences of reporting symptoms 
of substance-related disorders in the context of a primar-
ily somatic treatment environment. Finally, it is well 
known from international comparisons that substance-
related disorders are more frequent in US American sam-
ples  [31] .
 Prevalence rates of mental disorders differ significant-
ly between persons who have a chronic somatic disease 
and those who do not, while there are only slight differ-
ences in prevalence rates of mental disorders among the 
disease groups investigated. However, similar frequen-
cies between disease samples may be attributable to other 
inherent causes, such as a frequent comorbid somatic dis-
ease. Therefore, we calculated additional prevalence rates 
of mental disorders of patients with the respective index 
disease compared to those without the index disease, and 
adjusted for age, sex and number of somatic comorbidi-
ties. The OR for mental disorders proved to be very sim-
ilar between disease groups, highlighting once again the 
small differences of mental disorders between somatic 
diseases. However, patients who display more than 2 so-
matic diseases show an increased risk for mental disor-
ders of 40% in comparison with patients who have just 1 
somatic disease.
Table 3. Sex- and age-adjusted 12-month prevalence rates of DSM-IV mental disorders in patients with 1, 2, and more than 2 somatic 
diseases in comparison with healthy probands
1 disease (n = 421) 2 diseases (n = 526) >2 diseases (n = 1,363) Healthy
(n = 1,083)
%% OR 95% CI % OR 95% CI % OR 95% CI
Total1 34.4 1.6** 1.2–2.1 37.9 1.8** 1.4–2.4 48.2 2.8** 2.2–3.5 25.0
Mood disorders 15.5 1.8** 1.2–2.6 19.2 2.3** 1.6–3.3 24.4 3.1** 2.3–4.3 9.4
Anxiety disorders 21.2 2.1** 1.4–2.9 17.0 1.6* 1.1–2.2 26.5 2.8** 2.1–3.7 11.6
Somatoform disorders 9.4 1.7* 1.0–2.8 13.3 2.5** 1.7–3.8 18.8 3.8** 2.7–5.5 5.7
Substance use disorders2 5.4 1.0 0.5–1.9 6.4 1.2 0.7–2.2 8.3 1.6 1.0–2.6 5.3
More than one mental disorder 15.8 2.5** 1.6–3.8 16.9 2.7** 1.8–3.9 25.3 4.5** 3.2–6.2 7.1
* p < 0.05, ** p < 0.01 (two-tailed). OR are based on the adjusted prevalence rates of the physically healthy comparison group.
1 At least one of the mentioned disorders.
2 Excluding nicotine dependence.
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 This investigation tried to overcome the limitations of 
previous studies by using 2 large, independent samples 
with the same standardized interview procedure that cov-
ers a wide range of mental disorders. Furthermore, com-
prehensive physician-based medical diagnoses were used 
rather than self-reports of patients, as was the case in ear-
lier investigations. However, some  methodological issues 
should be noted. First, this is a cross-sectional study and 
therefore cannot demonstrate causal associations between 
somatic diseases and mental disorders. Moreover, the ef-
fect of depression-triggered mortality in some somatic 
diseases  [1, 32] on prevalence rates of mental disorders is 
not reflected in cross-sectional studies. Second, even 
though the CIDI is regarded as the gold standard for large 
epidemiological surveys, there are  limitations in terms of 
the reliability and validity  of some specific diagnoses  [22] . 
Third, the inpatient sample comprises mainly patients 
from rehabilitation centers. The similar prevalence rates 
within the 2 samples suggest, however, that the impact of 
the setting on prevalence rates of mental disorders is low. 
Fourth, for reasons of brevity, we used broad categories of 
somatic diseases. There is literature showing that the 
strength of association of at least some of these categories 
may vary depending on the specific diseases included  [33, 
34] . Therefore, the prevalence rates of mental disorders 
shown for somatic disease groups in our study should be 
examined for differences within disease groups (e.g. re-
spiratory tract disease: asthma, chronic obstructive pul-
monary disease; cardiovascular disease: hypertension, 
coronary diseases, myocardial infarction etc.).
 The findings underscore the overall  high impact  of co-
morbid mental disorders in patients with chronic somat-
ic diseases. Unfortunately, comorbid mental disorders of-
ten remain unrecognized and untreated  [35, 36] . Comor-
bid mental disorders can negatively influence  patients’ 
adherence to interventions and  effectiveness  of treatment, 
 quality of life ,  mortality and  costs of disease and care  [1–7] . 
Furthermore, psychosocial interventions can improve 
clinical outcomes in organic diseases  [4, 5, 32, 37–39] . 
Due to the large range of somatic and psychiatric diseas-
es, there are no general recommendations that can be 
made for effective treatments. However, a recent consen-
sus statement of experts on mood disorders in the medi-
cally ill highlighted evidence-based antidepressant and 
psychotherapy treatments for several medical conditions 
comprising disease-dependent antidepressants (selective 
serotonin reuptake inhibitors, tricyclic antidepressants 
etc.) and cognitive-behavioral therapy  [32] . More of these 
types of approaches are needed, particularly for further 
frequent disorders such as anxiety disorders.
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